Skip to main content
. 2025 Jan 29;111(3):2525–2534. doi: 10.1097/JS9.0000000000002269

Table 2.

Team familiarity and other determinants associated with adjusted surgical outcomes

Composite adverse event Major surgical complication Unplanned reoperation Extended ICU stay Death
Characteristic Odds ratio (95% CI)c P value Odds ratio (95% CI)c P value Odds ratio (95% CI)c P value Odds ratio (95% CI)c P value Odds ratio (95% CI)c P value
Surgical team familiaritya 0.92 (0.87–0.98) 0.007 0.93 (0.88–0.99) 0.015 0.88 (0.78–0.99) 0.027 0.88 (0.75–1.04) 0.132 0.87 (0.74–1.03) 0.101
Attending surgeon age 1.00 (0.99–1.02) 0.807 1.00 (0.99–1.02) 0.570 1.00 (0.98–1.02) 0.906 1.00 (0.98–1.02) 0.987 0.99 (0.96–1.02) 0.505
Attending surgeon status
 Non-professor - - - - -
 Associate/full professor 0.95 (0.74–1.23) 0.717 0.95 (0.73–1.24) 0.696 0.92 (0.66–1.28) 0.615 1.07 (0.72–1.59) 0.723 0.85 (0.57–1.27) 0.435
Assisting surgeon status - - - - -
 Junior
 Senior 1.35 (1.01–1.79) 0.041 1.35 (1.00–1.82) 0.049 1.22 (0.88–1.70) 0.229 1.14 (0.84–1.56) 0.393 1.25 (0.62–2.54) 0.528
Patient risk score quartile by surgical specialtyb
 Cardiac and thoracic (Q1) - - - - -
 Cardiac and thoracic (Q2) 1.22 (0.64–2.29) 0.545 1.29 (0.69–2.43) 0.420 1.05 (0.31–3.57) 0.940 1.07 (0.50–2.29) 0.858 2.71 (1.19–6.16) 0.017
 Cardiac and thoracic (Q3) 1.69 (1.25–2.29) <0.001 1.59 (1.20–2.09) 0.001 2.90 (1.09–7.74) 0.033 2.69 (1.16–6.24) 0.021 6.16 (3.50–10.8) <0.001
 Cardiac and thoracic (Q4) 3.49 (2.35–5.17) <0.001 3.21 (2.19–4.71) <0.001 5.91 (1.94–18.0) 0.002 5.81 (2.65–12.7) <0.001 16.4 (10.9–24.5) <0.001
 General and endocrine (Q1) 0.22 (0.15–0.32) <0.001 0.22 (0.14–0.33) <0.001 0.38 (0.11–1.26) 0.115 0.02 (0.00–0.13) <0.001 0.23 (0.05–1.04) 0.056
 General and endocrine (Q2) 0.56 (0.36–0.85) 0.006 0.56 (0.36–0.87) 0.010 0.64 (0.18–2.29) 0.495 0.11 (0.03–0.37) <0.001 0.12 (0.02–0.88) 0.037
 General and endocrine (Q3) 0.92 (0.62–1.36) 0.676 0.98 (0.66–1.44) 0.912 1.16 (0.37–3.63) 0.795 0.39 (0.15–1.01) 0.052 0.99 (0.44–2.26) 0.989
 General and Endocrine (Q4) 3.25 (2.26–4.68) <0.001 3.28 (2.29–4.70) <0.001 4.02 (1.34–12.1) 0.013 2.35 (1.01–5.47) 0.048 5.24 (2.72–10.1) <0.001
 Orthopedic and urogynecologic (Q1) 0.08 (0.05–0.12) <0.001 0.07 (0.04–0.11) <0.001 0.13 (0.04–0.45) 0.001 0.00 (0.00–0.00) <0.001 0.08 (0.01–0.82) 0.033
 Orthopedic and urogynecologic (Q2) 0.17 (0.11–0.25) <0.001 0.14 (0.09–0.22) <0.001 0.38 (0.12–1.27) 0.116 0.02 (0.00–0.17) <0.001 0.13 (0.04–0.45) 0.001
 Orthopedic and urogynecologic (Q3) 0.33 (0.23–0.48) <0.001 0.31 (0.22–0.45) <0.001 0.62 (0.19–2.02) 0.431 0.00 (0.00–0.00) <0.001 0.00 (0.00–0.00) <0.001
 Orthopedic and urogynecologic (Q4) 0.96 (0.64–1.44) 0.842 0.94 (0.62–1.42) 0.767 1.64 (0.52–5.15) 0.397 0.25 (0.07–0.93) 0.039 1.16 (0.51–2.63) 0.720
a

Surgical team familiarity was measured based on the number of previous collaborations between the attending and assisting surgeon and modeled using a logarithmic transformation.

b

Preoperative risk scores were developed for the five outcomes across the surgical specialties using a dataset of 3644 operations. The variables included demographics, surgical details, and comorbidities. Categories were based on quartiles (Q1-Q4) representing increasing adverse event rates by surgical specialty.

c

Abbreviations: CI = confidence interval.

We employed a multivariable generalized estimating equations (GEE) with an independent correlation matrix to model the association between patient outcomes and surgical team familiarity. The attending surgeon identity was considered in the models as a random effect, and possible interactions between the covariates were examined.